Back to top
more

Better trading starts here.

Brokerage Reports

Research for DVA

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

1 item in cart

View Cart/Checkout

DaVita Inc. [DVA]

Reports for Purchase

Showing records 201 - 220 ( 289 total )

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 201

04/08/2015

Company Report

Pages: 5

Lowering Estimates on 2016 MA Rate Guidance

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 202

04/08/2015

Daily Note

Pages: 7

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 203

03/24/2015

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 204

03/04/2015

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 205

02/13/2015

Company Report

Pages: 9

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 206

02/12/2015

Company Report

Pages: 8

4Q Results and Call Highlight Longer-Term Growth Uncertainties

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 207

01/16/2015

Company Report

Pages: 9

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 208

11/07/2014

Daily Note

Pages: 13

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 209

11/07/2014

Company Report

Pages: 8

Reducing Estimates on Lower Than Expected Guidance

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 210

11/07/2014

Company Report

Pages: 9

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 211

09/30/2014

Company Report

Pages: 9

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 212

09/17/2014

Daily Note

Pages: 25

Morning Meeting Notes

Provider: KEYBANC CAPITAL MARKETS

Price: 75.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 213

09/17/2014

Company Report

Pages: 7

Downgrading on Valuation/Slightly Lower Growth Outlook

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 214

08/01/2014

Company Report

Pages: 7

Solid 2Q; Reassuringly No Major Surprises at HCP

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 215

08/01/2014

Company Report

Pages: 9

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 216

07/16/2014

Company Report

Pages: 9

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 217

05/15/2014

Daily Note

Pages: 3

Discontinuation of Research Coverage

Provider: FELTL & COMPANY

Price: 10.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 218

05/02/2014

Daily Note

Pages: 8

Solid Kidney Care results overshadowed by weak HCP performance

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 219

05/02/2014

Company Report

Pages: 9

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 220

05/01/2014

Company Report

Pages: 8

Reducing Estimates Slightly as HCP Continues to Stumble

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party